PharVision Advisers’s Mattel MAT Stock Holding History

PharVision Advisers’s Portfolio MAT Stock Details MAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,544	Closed	-$177K	–	878
2025 Q3	$177K	Buy	+10,544	New	+$192K	0.1%	539

Other funds holding MAT

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PharVision Advisers's MAT Position: Q4 2025 in Review

PharVision Advisers sold out of Mattel (MAT) in Q4 2025, closing a stake of 10,544 shares — an estimated $177K sold.

PharVision Advisers first reported a position in MAT in Q3 2025 and held it in 1 quarter. The position peaked at $177K in Q3 2025. 441 funds tracked by Wall St. Rank hold MAT as of Q4 2025.

PharVision Advisers reported no remaining Mattel position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 10,544 Mattel shares in Q4 2025, an estimated $177K.
PharVision Advisers first reported a position in Mattel in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Mattel position peaked at $177K in Q3 2025.
441 funds tracked by Wall St. Rank held Mattel as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.